Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Graves Disease II: Pathophysiology

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...

Hyperthyroidism II: Pathophysiology

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...

Graves' Disease I: Introduction

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...

Hyperthyroidism I: Introduction

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...

Hypothyroidism II: Pathophysiology

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...

Myasthenia Gravis: Diagnostic Tests

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Reply to "Comment on 'Identifying high glucose variability using non-glycemic factors in low continuous glucose monitoring use settings'".

Primary care diabetes·2026

Same author

Relationship between continuous glucose monitoring and corneal neuropathy in type 2 diabetes.

The Journal of clinical endocrinology and metabolism·2026

Same author

Differential impact of timing of nocturnal hypoglycemia on subjective sleep quality in people with type 1 diabetes.

Sleep medicine·2025

Same author

Continuous Glucose Monitoring Metrics in Asians Without Diabetes: Differentiating Prediabetes From Normoglycemia.

Journal of diabetes science and technology·2025

Same author

Identifying high glucose variability using non-glycemic factors in low continuous glucose monitoring use settings.

Primary care diabetes·2025

Same author

Ectopic Parathyroid Hormone Expression in Nonmetastatic Prostate Cancer.

JCEM case reports·2025

Search research articles

Related Experiment Video

Updated: May 28, 2026

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

Thyrotoxic periodic paralysis.

Rojith Karanode Balakrishnan¹, Suresh Rama Chandran, Geetha Thirumalnesan

¹Department of General Medicine, Coimbatore Medical College Hospital, Coimbatore, India.

Indian Journal of Endocrinology and Metabolism

|October 4, 2011

Summary

Thyrotoxic periodic paralysis (TPP) can cause recurrent muscle weakness, especially in Asian men. Early diagnosis of thyrotoxicosis is crucial for prompt treatment and full recovery.

Keywords:

Acute flaccid periodic paralysis genetic predisposition hypokalemia oral potassium thyrotoxicosis

More Related Videos

Investigation of the Electrophysiological and Thermographic Safety Parameters of Surgical Energy Devices During Thyroid and Parathyroid Surgery in a Porcine Model

Investigation of the Electrophysiological and Thermographic Safety Parameters of Surgical Energy Devices During Thyroid and Parathyroid Surgery in a Porcine Model

Published on: October 13, 2022

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on: July 14, 2023

Related Experiment Videos

Last Updated: May 28, 2026

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

Investigation of the Electrophysiological and Thermographic Safety Parameters of Surgical Energy Devices During Thyroid and Parathyroid Surgery in a Porcine Model

Investigation of the Electrophysiological and Thermographic Safety Parameters of Surgical Energy Devices During Thyroid and Parathyroid Surgery in a Porcine Model

Published on: October 13, 2022

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on: July 14, 2023

Area of Science:

Endocrinology
Neurology

Background:

Thyrotoxic periodic paralysis (TPP) is a potentially debilitating complication of thyrotoxicosis.
It disproportionately affects males of Asian descent, presenting as episodic muscle weakness.
Subtle or absent hyperthyroid symptoms can delay diagnosis.

Observation:

A case report details a 28-year-old male with recurrent episodes of flaccid paralysis.
The patient presented with hypokalemia, identified as secondary to thyrotoxicosis.
Prompt oral potassium administration led to complete recovery within 24 hours.

Findings:

The presented case confirms TPP as a cause of recurrent hypokalemic periodic paralysis.
Early suspicion of thyrotoxicosis is vital, even with mild or absent hyperthyroid signs.
Effective management involves addressing both hypokalemia and the underlying thyrotoxicosis.

Implications:

Highlights the importance of considering TPP in patients with unexplained periodic paralysis.
Emphasizes the need for thyroid function testing in affected individuals, particularly Asian men.
Facilitates earlier diagnosis and treatment, preventing long-term complications and improving patient outcomes.